Proprietary small-molecule cocktail significantly improves post-passaging recovery, cryopreservation outcomes, and long-term expansion of sensitive cell cultures. MONMOUTH JUNCTION, N.J., July7, 2026 — TheWell Bioscience, a leader in xeno-free 3D cell culture technologies, today announced the commercial launch of RocketCell™ Cell Viability Enhancer, a proprietary small-molecule formulation designed to maximize cell survival, metabolic recovery, and growth […]
Monmouth Junction, NJ — May 19, 2026 — TheWell Bioscience, a biotechnology pioneering advanced 3D cell culture technologies, today announced the launch of its RocketCell™ Organoid Xeno-Free Essential-Core Medium, a chemically defined, universal foundation medium designed to streamline organoid culture workflows while enhancing reproducibility, scalability, and cost efficiency. As organoid models continue to expand across […]
Monmouth Junction, NJ — March 4, 2026 — TheWell Bioscience, a leader in advanced xeno-free cell culture technologies, today announced the launch of RocketCell™ hMSC Xeno-Free Complete Growth Medium, a chemically defined, xeno-free medium engineered for high-performance human mesenchymal stem cell (hMSC) expansion across research, translational development, and cell therapy manufacturing workflows. As regulatory agencies […]
A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate Monmouth Junction, NJ — February 9, 2026 — TheWell Bioscience today announced the launch of the VitroPrime™ 3D Culture and Imaging Plate, a next-generation 3D cell culture plate engineered to support organoid and advanced […]
Monmouth Junction, NJ – January 14, 2026 – TheWell Bioscience is proud to announce the commercial launch of its new RocketCell™ product line, introducing two cutting-edge solutions for stem cell research: the RocketCell™ 3D iPSC Xeno-Free Complete Growth Kit and the RocketCell™ iPSC Xeno-Free Growth Medium. These products are engineered to resolve critical bottlenecks in […]
Monmouth Junction, NJ and Tokyo, Japan — January 7, 2026 — TheWell Bioscience Inc., a biotechnology company pioneering next-generation animal-free biofunctional hydrogels, and PeptiGrowth Inc., a leader in innovative synthetic peptide growth factors, today announced that the two companies have entered into a Marketing Collaboration Agreement to jointly promote cutting-edge solutions for stem cell culture, […]
Monmouth Junction, NJ | February 20, 2025 — TheWell Bioscience Inc., a leading biotech company specializing in xeno-free biofunctional hydrogels and bioinks, is pleased to announce the distribution of its products through REGEMAT 3D, a leading biotech company specializing in the development of custom biofabrication systems, to distribute VitroINK®, a groundbreaking bioink in the field […]
Göttingen, Germany | April 9, 2024 Collaboration to advance TheWell Bioscience animal-free hydrogel solutions for 3D cell models Solutions address shift from animal-based to more human-relevant organoid models, resulting in more accurate predictions in drug discovery Synergies with Sartorius bioanalytical lab instruments for cell imaging The life science group Sartorius and U.S.-based startup TheWell Bioscience […]
NORTH BRUNSWICK, N.J., Dec. 18, 2023 /PRNewswire/ — TheWell Bioscience, a pioneer of 3D biomimicking platforms for precision medicine, cell therapy, and biomanufacturing, announces the launch of VitroGel®-Based Cell Invasion Assay Kits. Using the xeno-free VitroGel® hydrogels, these new kits revolutionize how researchers study cell migration and invasion, offering unprecedented accuracy, efficiency, and reliability for cell migration assays. […]
TheWell Bioscience has launched a newly engineered version of its cell recovery solution for researchers to speed the organoid/cell harvesting from both animal-based extracellular matrix (ECM) and synthetic hydrogels. NEW BRUNSWICK, N.J., Feb. 21, 2023 /PRNewswire/ — TheWell Bioscience, a pioneer of 3D cell culture platforms for precision medicine, cell therapy, and biomanufacturing, releases a newly engineered […]
